MAY 14, 2019 11:52 AM PDT

EU Weighs Options for Massive Cancer Research Mission

WRITTEN BY: Julia Travers

The European Union (EU) is considering whether and how to launch a moon shot cancer research mission -- a massive commitment and investment in curing cancer. The effort is led by EU Research Commissioner Carlos Moedas, who said in April 2019, “Cancer has evolved and we need new tactics to match it. We need the scale and the critical mass at the EU level, to give it our best shot.” Not surprisingly, how to go about building such an endeavor and where to direct resources are sources of much debate within the union.

Carlos Moedas, credit: UCL Mathematical & Physical Sciences on Flickr, CC 2.0

As more people live longer, cancer is also on the rise. According to the International Agency for Research on Cancer, the number of new incidences of cancer per year will reach more than 22 million by 2030. Cancer is a serious issue in the EU, which holds less than 10 percent of the world’s population but more than 25 percent of cancer cases, according to Science Business.

One of the key theories behind the proposed research mission is increased connectivity between EU governments and the myriad professionals whose work relates to cancer. Moedas is calling for bridges to be built between researchers, various academic disciplines, drug companies and government agencies.

“Focusing on oncologists is no longer enough for cancer treatment. We need oncologists, nutritionists, economists and the patients themselves. We should leverage the European networks we have already on cancer,” he said. An association of seven European cancer centers called Cancer Core Europe wants to be the “engine” of the new mission.

This undertaking would fall within the EU’s “Horizon Europe” research program, which will run from 2021 to 2027. Other goals being considered within this plan include cutting back on plastic pollution and building quantum computers. Horizon Europe has a proposed budget of 94.1 billion euros (~ $105.51 billion), but Christian Ehler, one of the lead authors of the new undertaking, said more money is needed. At this level, he said, “You don’t see missions. At 125 billion euros, you can see missions, at 160 billion euros you can start to fight Alzheimer’s.”

Whether to target specific cancers and, if so, which ones, is also a point of contention.

Map of EU, credit: public domain

 

Source: Science Business

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
SEP 23, 2021
Drug Discovery & Development
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
SEP 23, 2021
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
Last week, the United States Food and Drug Administration (FDA) granted approval for the first oral therapy to ...
OCT 09, 2021
Cell & Molecular Biology
The Anti-Cancer, Copper-Binding Compounds Found in Fish
OCT 09, 2021
The Anti-Cancer, Copper-Binding Compounds Found in Fish
In the world's waterways, fish are confronted with endless challenges. For example, they have to defend themselves from ...
OCT 21, 2021
Cancer
Exercise: A Secret Weapon to Combat Prostate Cancer?
OCT 21, 2021
Exercise: A Secret Weapon to Combat Prostate Cancer?
Exercise oncology is an evolving science that considers the addition of physical activity regimens to the treatment ...
OCT 24, 2021
Microbiology
New Treatment Approach Uses Bacteria to Deliver Drugs to Cancer Cells
OCT 24, 2021
New Treatment Approach Uses Bacteria to Deliver Drugs to Cancer Cells
Bacteria can be found almost everywhere, and they can serve many beneficial purposes. Scientists are now using bacterial ...
NOV 23, 2021
Clinical & Molecular DX
Scientists Enter Uncharted Territory of the Cancer Genome, Emerge Victorious
NOV 23, 2021
Scientists Enter Uncharted Territory of the Cancer Genome, Emerge Victorious
Cancer is a genetic disease—it stems from specific changes in the DNA sequences of the cancer cell genome. Over th ...
NOV 29, 2021
Cancer
An Amino Acid Can Improve Radiation Therapy for Metastatic Brain Cancer
NOV 29, 2021
An Amino Acid Can Improve Radiation Therapy for Metastatic Brain Cancer
There are 20 different amino acids that the human body uses to generate proteins.  Amino acids form chains called p ...
Loading Comments...